367 related articles for article (PubMed ID: 32079254)
1. Hepatitis C Virus Vaccine: Challenges and Prospects.
Duncan JD; Urbanowicz RA; Tarr AW; Ball JK
Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32079254
[TBL] [Abstract][Full Text] [Related]
2. A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.
Baumert TF; Fauvelle C; Chen DY; Lauer GM
J Hepatol; 2014 Nov; 61(1 Suppl):S34-44. PubMed ID: 25443345
[TBL] [Abstract][Full Text] [Related]
3. Methods to Evaluate Novel Hepatitis C Virus Vaccines.
Ahlén G; Frelin L
Methods Mol Biol; 2016; 1403():221-44. PubMed ID: 27076133
[TBL] [Abstract][Full Text] [Related]
4. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?
Echeverría N; Comas V; Aldunate F; Perbolianachis P; Moreno P; Cristina J
World J Hepatol; 2021 Oct; 13(10):1234-1268. PubMed ID: 34786164
[TBL] [Abstract][Full Text] [Related]
5. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
6. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
Bukh J
J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis viruses and liver transplantation.
Samuel D; Feray C; Bismuth H
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
[TBL] [Abstract][Full Text] [Related]
8. Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.
Alvarez-Lajonchere L; Dueñas-Carrera S
Int Rev Immunol; 2012 Jun; 31(3):223-42. PubMed ID: 22587022
[TBL] [Abstract][Full Text] [Related]
9. Progress towards a hepatitis C virus vaccine.
Man John Law L; Landi A; Magee WC; Lorne Tyrrell D; Houghton M
Emerg Microbes Infect; 2013 Nov; 2(11):e79. PubMed ID: 26038445
[TBL] [Abstract][Full Text] [Related]
10. Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance.
Merat SJ; Bru C; van de Berg D; Molenkamp R; Tarr AW; Koekkoek S; Kootstra NA; Prins M; Ball JK; Bakker AQ; de Jong MD; Spits H; Beaumont T; Schinkel J
J Hepatol; 2019 Jul; 71(1):14-24. PubMed ID: 30797052
[TBL] [Abstract][Full Text] [Related]
11. A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.
Urbanowicz RA; McClure CP; Brown RJ; Tsoleridis T; Persson MA; Krey T; Irving WL; Ball JK; Tarr AW
J Virol; 2015 Dec; 90(7):3288-301. PubMed ID: 26699643
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding hepatitis C.
Douam F; Ding Q; Ploss A
F1000Res; 2016; 5():. PubMed ID: 26918166
[TBL] [Abstract][Full Text] [Related]
13. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus: molecular biology & current therapeutic options.
Sharma SD
Indian J Med Res; 2010 Jan; 131():17-34. PubMed ID: 20167971
[TBL] [Abstract][Full Text] [Related]
15. Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.
Feinstone SM; Hu DJ; Major ME
Clin Infect Dis; 2012 Jul; 55 Suppl 1():S25-32. PubMed ID: 22715210
[TBL] [Abstract][Full Text] [Related]
16. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic vaccines against hepatitis C virus.
Xue J; Zhu H; Chen Z
Infect Genet Evol; 2014 Mar; 22():120-9. PubMed ID: 24462908
[TBL] [Abstract][Full Text] [Related]
18. Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?
Abdelwahab SF
Infect Agent Cancer; 2016; 11():23. PubMed ID: 27186234
[TBL] [Abstract][Full Text] [Related]
19. Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design.
Roohvand F; Kossari N
Expert Opin Ther Pat; 2011 Dec; 21(12):1811-30. PubMed ID: 22022980
[TBL] [Abstract][Full Text] [Related]
20. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
